Michael J. Pencina
Cardiology and Cardiovascular Medicine · 2004–2023
A researcher in the Science corpus: 29 papers; trusts 15 researchers and is trusted by 18 researchers here, as inferred from the citation graph.
Subfields
- Cardiology and Cardiovascular Medicine — 172 citations into it; #155 of 906 by trust here, #27 by citations
- Endocrinology, Diabetes and Metabolism — 122 citations into it; #160 of 623 by trust here, #68 by citations
- Surgery — 94 citations into it
- Statistics and Probability — 70 citations into it; #3,228 of 12,932 by trust here, #830 by citations
- Epidemiology — 41 citations into it
- Pulmonary and Respiratory Medicine — 29 citations into it
- Economics and Econometrics — 28 citations into it; #11,981 of 23,481 by trust here, #3,225 by citations
- Genetics — 13 citations into it
Whom Michael J. Pencina trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Ralph B. D’Agostino
- James A. Hanley
- Nancy R. Cook
- William N. Venables
- Andrew J. Vickers
- Sunil Rao
- B. Nam
- Peihua Qiu
- W. Hoeffding
- Peter W. F. Wilson
Who trusts Michael J. Pencina overall
- Ewout W. Steyerberg
- Karel G. M. Moons
- Hajime Uno
- J. Ho
- Jay P. Singh
- Louis Mayaud
- Ping Wang
- Ralph B. D’Agostino
- Chunyu Liu
- Ramachandran S. Vasan
Papers from Michael J. Pencina's perspective
Ordered by how strongly the researchers Michael J. Pencina trusts endorse each paper. Same corpus, a different order for every researcher.
- Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. (The Lancet)
- What do we mean by validating a prognostic model? (Statistics in Medicine)
- Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis
- Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). (Circulation)
- Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. (American Journal of Epidemiology)
- The Statistical Evaluation of Medical Tests for Classification and Prediction
- Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. (Journal of the American College of Cardiology)
- Estimation of time‐dependent area under the ROC curve for long‐term risk prediction (Statistics in Medicine)
- Decision Curve Analysis: A Novel Method for Evaluating Prediction Models
- A Class of Statistics with Asymptotically Normal Distribution
Their papers
- Opportunities and challenges in developing risk prediction models with electronic health records data: a systematic review (2017) — 840 citations
- Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers (2010) — 2,465 citations
- Assessing the performance of prediction models: a framework for some traditional and novel measures (2010) — 4,522 citations
- A calibration hierarchy for risk models was defined: from utopia to empirical data. (2016) — 729 citations
- Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation (2004) — 1,464 citations
- Misuse of DeLong test to compare AUCs for nested models (2012) — 290 citations
- On the C-statistics for Evaluating Overall Adequacy of Risk Prediction Procedures with Censored Survival Data (2011) — 1,473 citations
- Arterial stiffness and cardiovascular events: The Framingham Heart Study (2010) — 2,122 citations
- Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association (2023) — 1,292 citations
- Development and Validation of the American Heart Association Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Equations (2023) — 707 citations
- A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association (2023) — 862 citations
- Overlap Weighting: A Propensity Score Method That Mimics Attributes of a Randomized Clinical Trial. (2020) — 632 citations
- Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial (2019) — 968 citations
- Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. (2015) — 2,285 citations
- Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy (2014) — 917 citations
- Application of new cholesterol guidelines to a population-based sample. (2014) — 628 citations
- Simple Risk Model Predicts Incidence of Atrial Fibrillation in a Racially and Geographically Diverse Population: the CHARGE‐AF Consortium (2013) — 792 citations
- Diagnostic Accuracy of Fractional Flow Reserve From Anatomic CT Angiography (2012) — 1,158 citations
- Galectin-3, a Marker of Cardiac Fibrosis, Predicts Incident Heart Failure in the Community (2012) — 596 citations
- Improved Cardiac Risk Assessment With Noninvasive Measures of Coronary Flow Reserve (2011) — 781 citations